Alan Nurden: One of The Best Articles That I Have Read in 2025
Alan Nurden, Emeritus Research Director at CNRS, shared on LinkedIn:
”One of the best articles that I have read in 2025.
The wide-ranging pathophysiology of RUNX1 mutations is clearly illustrated through a series of case reports where families were gentotyped using a NGS-based sequencing panel.
The association of platelet function defects, thrombocytopenia and malignancy risk is highlighted case by case in a thoroughly professional manner.
Highly recommended.”
Read the full article in Frontiers.
Article: RUNX1-FPDMM in families with mild thrombocytopenia and platelet function anomalies: a case series
Authors: Hannah Glonnegger, Doris Boeckelmann, Rebekka Wiedenhöfer, Wolf-Achim Hassenpflug, Tim Ripperger, Dirk Lebrecht, Ralf Knöfler, Oliver Tiebel, Udo Koehler, Claudia Wehr, Harry Sirb, Monika Sparber-Sauer, Katrin Reinsberger, Ayami Yoshimi, Brigitte Strahm, Barbara Zieger

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 8, 2026, 12:22Marc Carrier: Advancing Catheter-Related Thrombosis Prevention Through Factor XI Inhibition
-
Nov 8, 2026, 11:56Why Genetic Predisposition Does Not Always Lead to Thrombosis – Stork Genetics
-
Nov 8, 2026, 11:45Sher-Lu Pai: Investigating Intracardiac Thrombosis and Its Management in Liver Transplantation
-
Nov 8, 2026, 11:25Mehmet Cilingiroglu: Navigating Anticoagulation Choices in Acute Coronary Syndrome PCI
-
Nov 8, 2026, 07:16Gilberto de lima Lopes Junior: The Cardiovascular Consequences of Cancer in Younger Patients
-
Nov 8, 2026, 06:51Haney Mallemat: Key Principles and Pitfalls of LVAD Emergencies
-
Nov 8, 2026, 06:31Maria Omer: Clinical Recognition and Management of Cavernous Sinus Thrombosis
-
Nov 8, 2026, 06:16Natasha Jolakoski: University of New Mexico Hospital Promotes PGY-2 Thrombosis and Hemostasis Management Pharmacy Residency
-
Nov 8, 2026, 05:47Safaa Hilal: POCUS in the Evaluation of Perioperative Troponin Elevation